Meet the person behind Irwin Naturals Inc. (CSE:IWIN) (OTC: IWINF), an herbal supplement formulator and leader in the nutrition industry at the forefront of the "psychedelics renaissance."
Klee Irwin serves as CEO and chairman of Irwin Naturals and director of Quantum Gravity Research, a non-profit research institute he founded in 2009.
The southern California native at the helm of the highly profitable $134 million brand known by 80% of US and Canadian households is also an author, physicist and businessman "on a personal mission to raise consciousness on the planet through scientific breakthroughs that lead to solutions for advancing humanity."
This year, at the upcoming Benzinga Psychedelics Capital Conference, to be held on April 19 at the Fontainebleau Miami Beach Hotel in Florida, Irwin will deliver the keynote speech and share his vision and valuable insights with the burgeoning sector.
Irwin founded the Irwin Naturals in 1994. Since then, the company has grown to a global natural supplement enterprise providing alternative health and healing products sold that are sold at number of retailers, including Costco (NASDAQ: COST), Walmart (NYSE: WMT), CVS (NYSE: CVS) and Whole Foods.
Having a portfolio of herbal products available in 100,000 doors across North America, the world's first household brand to move into cannabis and psychedelics mental health treatment is on a mission to heal the world with plant medicine.
CBD As A New Frontier
The nearly three decades old legacy company and long-time supporter of Vitamin Angels began investing in the development of products infused with cannabidiol in 2017.
Over 100 CBD products, across four brand categories, were birthed from the company's R&D effort, including Irwin Naturals brand for CBD infused oil drops, supplements and balms. These include HydroCanna for CBD skincare launched in 2020, FloChi for CBD based foods and beverages and Love My Pet for animals.
The company first leveraged its established brand to enter into the cannabinoid space in 2018 by launching CBD products into the mass market.
The company began trading on the Canadian Stock Exchange In August of 2021, on the heels of closing a reverse takeover of Datinvest International Ltd. to create a combined entity that ...psychedelics investing stock exchange trading cse nasdaq otc research